PMID- 22490596 OWN - NLM STAT- MEDLINE DCOM- 20120803 LR - 20120411 IS - 2542-5641 (Electronic) IS - 0366-6999 (Linking) VI - 125 IP - 5 DP - 2012 Mar TI - A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats. PG - 912-9 AB - BACKGROUND: Bariatric surgery offers successful resolution of type 2 diabetes mellitus (T2DM). However, recurrence of T2DM has been observed in a number of patients with initial resolution after bariatric surgery. This study aimed to induce reversal of the improvement of diabetes in T2DM rats after duodenal-jejunal bypass (DJB), and identify the effects of weight changes and gut hormones that might be involved. METHODS: DJB surgery was performed in two T2DM rat models (n=20 for each group): non-obese Goto-Kakizaki (GK) rats, and moderately-obese T2DM rats induced by a combination of a high-fat diet (HFD) and low-dose streptozotocin (HS rats). The controls were sham-operated and non-treated rats. All rats were then randomly divided into HFD- and low-fat diet (LFD)-fed groups. Glucose tolerance, insulin tolerance, glucose-stimulated insulin, glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) secretion, food intake and body weight were measured and compared with controls. RESULTS: DJB surgery resulted in a significant improvement in glucose tolerance in both GK and HS rats fed with either HFD or LFD. In contrast to LFD-fed rats, improved glucose tolerance was impaired in GK and HS rats fed with an HFD, accompanied by re-impairment of insulin tolerance and failure in enhancement of insulin secretion. There was no significant difference in food intake and body weight between DJB-operated and control rats, and between HFD- and LFD-fed rats. Glucose-stimulated GLP-1 and PYY levels were significantly increased after DJB surgery; however, they were not significantly different between HFD- and LFD-fed rats. CONCLUSION: An HFD reverses the improvement in glucose tolerance induced by DJB surgery in T2DM rats, primarily ascribing to the re-impairment of insulin sensitivity, but does not change body weight, GLP-1 and PYY levels. FAU - Liu, Shao-zhuang AU - Liu SZ AD - Department of General Surgery, Qilu Hospital of Shandong University, Experimental Center, School of Chemistry and Chemical Engineering, Shandong University, Jinan, Shandong 250012, China. FAU - Sun, Dong AU - Sun D FAU - Zhang, Guang-yong AU - Zhang GY FAU - Wang, Lei AU - Wang L FAU - Liu, Teng AU - Liu T FAU - Sun, Yu AU - Sun Y FAU - Li, Ming-xia AU - Li MX FAU - Hu, San-yuan AU - Hu SY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Chin Med J (Engl) JT - Chinese medical journal JID - 7513795 RN - 0 (Blood Glucose) SB - IM MH - Animals MH - Blood Glucose/drug effects MH - Diabetes Mellitus, Type 2/blood/*chemically induced/pathology/*surgery MH - Diet, High-Fat/*adverse effects MH - *Gastric Bypass MH - Glucose Tolerance Test MH - Male MH - Rats MH - Rats, Sprague-Dawley EDAT- 2012/04/12 06:00 MHDA- 2012/08/04 06:00 CRDT- 2012/04/12 06:00 PHST- 2012/04/12 06:00 [entrez] PHST- 2012/04/12 06:00 [pubmed] PHST- 2012/08/04 06:00 [medline] PST - ppublish SO - Chin Med J (Engl). 2012 Mar;125(5):912-9.